Frank Borriello, MD, PhD

Articles by Frank Borriello, MD, PhD

Frank Borriello, MD, PhD, on Next Steps for SUPLEXA-101 for Solid Tumors

June 26th 2023

The scientific cofounder and chief executive officer of Alloplex Biotherapeutics discussed progress of the phase 1 trial and possible future evaluations of the therapy.

Frank Borriello, MD, PhD, on Promising Activity of SUPLEXA-101 Across Cancers

ByFrank Borriello, MD, PhD

April 27th 2023

The scientific cofounder and chief executive officer of Alloplex Biotherapeutics discussed early data from a phase 1 trial of the PBMC-derived therapy.

Frank Borriello, MD, PhD

Articles by Frank Borriello, MD, PhD

Frank Borriello, MD, PhD, on Next Steps for SUPLEXA-101 for Solid Tumors

Frank Borriello, MD, PhD, on Promising Activity of SUPLEXA-101 Across Cancers

Latest Updated Articles